Lumpy Skin Disease in 2026: Why the Goatpox Vaccine Isn't Enough
A new April 2026 Springer study confirms the Uttarkashi-strain goatpox vaccine provides inadequate protection against modern LSD. Here is the latest on symptoms, the Lumpi-ProVacInd vaccine, and state resources.
Lumpy Skin Disease (LSD) continues to pose a significant threat to dairy farming and cattle health across India. For years, veterinarians and state animal husbandry departments have relied on heterologous vaccines—specifically the goatpox vaccine (Uttarkashi strain)—to provide cross-protection against LSD.
However, a breakthrough study published in a leading Springer journal in April 2026 has confirmed what many field veterinarians suspected: the Uttarkashi-strain goatpox vaccine provides inadequate long-term immunity against modern LSD variants.
This finding is causing a surge in searches among farmers looking for answers on how to protect their herds. Here is the scientific reality, symptoms to watch out for, and the vaccine that actually works.
